首页 > 最新文献

JAMA Network Open最新文献

英文 中文
Hypotension and Adverse Outcomes in Moderate to Severe Traumatic Brain Injury: A Systematic Review and Meta-Analysis. 中度至重度创伤性脑损伤中的低血压与不良后果:系统回顾和元分析》。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.44465
Jun Won Lee, Wendy Wang, Amal Rezk, Ayman Mohammed, Kyle Macabudbud, Marina Englesakis, Abhijit Lele, Frederick A Zeiler, Tumul Chowdhury

Importance: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Hypotension in patients with TBI is associated with poorer outcomes. A comprehensive review examining adverse outcomes of hypotension in patients with TBI is needed.

Objective: To investigate the mortality and incidence of hypotension in patients with TBI.

Data sources: A search of studies published before April 2024 was conducted using MEDLINE, MEDLINE In Process, ePubs, Embase, Classic+Embase, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews for primary research articles in English, including randomized control trials, quasirandomized studies, prospective cohorts, retrospective studies, longitudinal studies, and cross-sectional surveys.

Study selection: Inclusion criteria were patients aged at least 10 years with moderate to severe TBI with hypotension. The exclusion criteria were mild TBI (due to the differences in management principles from moderate to severe TBI). Data were screened using Covidence software with multiple reviewers.

Data extraction and synthesis: This meta-analysis conforms to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guidelines for assessing data quality and validity. Primary outcomes (unadjusted and adjusted odds ratios [ORs]) were calculated using a random-effect model with 95% CIs. Incidence of hypotension was derived using logit transformation.

Main outcomes and measures: Main outcomes were association of hypotension with death and/or vegetative state within 6 months and incidence of hypotension. Vegetative state was not reported due to lack of data from included studies. Hypothesis testing occurred before data collection.

Results: The search strategy identified 17 676 unique articles. The final review included 51 studies (384 329 patients). Pooled analysis of found a significant increase in mortality in patients with hypotension and moderate to severe TBI (crude OR, 3.82; 95% CI, 3.04-4.81; P < .001; I2 = 96.98%; adjusted OR, 2.22; 95% CI, 1.96-2.51; P < .001; I2 = 92.21%). The overall hypotension incidence was 18% (95% CI, 12%-26%) (P < .001; I2 = 99.84%).

Conclusions and relevance: This meta-analysis of nearly 400 000 patients with TBI found a significant association of greater than 2-fold odds of mortality in patients with hypotension and TBI. This comprehensive analysis can guide future management recommendations, specifically with respect to blood pressure threshold management to reduce deaths when treating patients with TBI.

重要性:创伤性脑损伤(TBI)是导致全球死亡和残疾的主要原因。创伤性脑损伤患者低血压与较差的预后有关。需要对创伤性脑损伤患者低血压的不良后果进行全面审查:调查创伤性脑损伤患者低血压的死亡率和发生率:数据来源:使用 MEDLINE、MEDLINE In Process、ePubs、Embase、Classic+Embase、Cochrane Central Register of Controlled Trials 和 Cochrane Database of Systematic Reviews 对 2024 年 4 月之前发表的研究进行检索,以获取英文的主要研究文章,包括随机对照试验、准随机研究、前瞻性队列、回顾性研究、纵向研究和横断面调查:纳入标准:年龄至少 10 岁、患有中度至重度创伤性脑损伤并伴有低血压的患者。排除标准为轻度创伤性脑损伤(由于管理原则与中度至重度创伤性脑损伤不同)。使用Covidence软件筛选数据,并有多名审稿人参与:本荟萃分析符合系统综述和荟萃分析首选报告项目(PRISMA)和流行病学观察性研究荟萃分析(MOOSE)报告指南,用于评估数据质量和有效性。主要结果(未调整和调整后的几率比 [ORs])采用随机效应模型和 95% CIs 计算。低血压发生率通过对数转换得出:主要结果为低血压与 6 个月内死亡和/或植物人的相关性以及低血压的发生率。由于缺乏纳入研究的数据,未报告植物状态。假设检验在数据收集之前进行:搜索策略共发现 17 676 篇文章。最后的综述包括 51 项研究(384 329 名患者)。汇总分析发现,低血压和中重度创伤性脑损伤患者的死亡率显著增加(粗OR,3.82;95% CI,3.04-4.81;P 结论和相关性:这项对近 40 万名创伤性脑损伤患者进行的荟萃分析发现,低血压和创伤性脑损伤患者的死亡率有超过 2 倍的显著相关性。这项综合分析可为未来的管理建议提供指导,特别是在治疗创伤性脑损伤患者时,如何管理血压阈值以减少死亡。
{"title":"Hypotension and Adverse Outcomes in Moderate to Severe Traumatic Brain Injury: A Systematic Review and Meta-Analysis.","authors":"Jun Won Lee, Wendy Wang, Amal Rezk, Ayman Mohammed, Kyle Macabudbud, Marina Englesakis, Abhijit Lele, Frederick A Zeiler, Tumul Chowdhury","doi":"10.1001/jamanetworkopen.2024.44465","DOIUrl":"10.1001/jamanetworkopen.2024.44465","url":null,"abstract":"<p><strong>Importance: </strong>Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Hypotension in patients with TBI is associated with poorer outcomes. A comprehensive review examining adverse outcomes of hypotension in patients with TBI is needed.</p><p><strong>Objective: </strong>To investigate the mortality and incidence of hypotension in patients with TBI.</p><p><strong>Data sources: </strong>A search of studies published before April 2024 was conducted using MEDLINE, MEDLINE In Process, ePubs, Embase, Classic+Embase, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews for primary research articles in English, including randomized control trials, quasirandomized studies, prospective cohorts, retrospective studies, longitudinal studies, and cross-sectional surveys.</p><p><strong>Study selection: </strong>Inclusion criteria were patients aged at least 10 years with moderate to severe TBI with hypotension. The exclusion criteria were mild TBI (due to the differences in management principles from moderate to severe TBI). Data were screened using Covidence software with multiple reviewers.</p><p><strong>Data extraction and synthesis: </strong>This meta-analysis conforms to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) reporting guidelines for assessing data quality and validity. Primary outcomes (unadjusted and adjusted odds ratios [ORs]) were calculated using a random-effect model with 95% CIs. Incidence of hypotension was derived using logit transformation.</p><p><strong>Main outcomes and measures: </strong>Main outcomes were association of hypotension with death and/or vegetative state within 6 months and incidence of hypotension. Vegetative state was not reported due to lack of data from included studies. Hypothesis testing occurred before data collection.</p><p><strong>Results: </strong>The search strategy identified 17 676 unique articles. The final review included 51 studies (384 329 patients). Pooled analysis of found a significant increase in mortality in patients with hypotension and moderate to severe TBI (crude OR, 3.82; 95% CI, 3.04-4.81; P < .001; I2 = 96.98%; adjusted OR, 2.22; 95% CI, 1.96-2.51; P < .001; I2 = 92.21%). The overall hypotension incidence was 18% (95% CI, 12%-26%) (P < .001; I2 = 99.84%).</p><p><strong>Conclusions and relevance: </strong>This meta-analysis of nearly 400 000 patients with TBI found a significant association of greater than 2-fold odds of mortality in patients with hypotension and TBI. This comprehensive analysis can guide future management recommendations, specifically with respect to blood pressure threshold management to reduce deaths when treating patients with TBI.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2444465"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142621050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rhabdomyolysis and Sodium-Glucose-Linked Transport Inhibitors in Patients Taking Statins. 服用他汀类药物患者的横纹肌溶解症与钠-葡萄糖转运抑制剂。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.46641
Ziv Harel, Nivethika Jeyakumar, Graham Smith, Joel G Ray, Kristin K Clemens, David N Juurlink
{"title":"Rhabdomyolysis and Sodium-Glucose-Linked Transport Inhibitors in Patients Taking Statins.","authors":"Ziv Harel, Nivethika Jeyakumar, Graham Smith, Joel G Ray, Kristin K Clemens, David N Juurlink","doi":"10.1001/jamanetworkopen.2024.46641","DOIUrl":"10.1001/jamanetworkopen.2024.46641","url":null,"abstract":"","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2446641"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142621080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error in Figure 1. 图 1 中的错误。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.49465
{"title":"Error in Figure 1.","authors":"","doi":"10.1001/jamanetworkopen.2024.49465","DOIUrl":"10.1001/jamanetworkopen.2024.49465","url":null,"abstract":"","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2449465"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142636056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients With Advanced Non-Small Cell Lung Cancer. 通过 RNA-NGS 和 DNA-NGS 对晚期非小细胞肺癌患者进行可操作的结构变异检测。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.42970
Dwight Owen, Rotem Ben-Shachar, Josephine Feliciano, Lisa Gai, Kyle A Beauchamp, Zachary Rivers, Adam J Hockenberry, Genelle Harrison, John Guittar, Catarina Catela, Jerod Parsons, Ezra Cohen, Kate Sasser, Halla Nimeiri, Justin Guinney, Jyoti Patel, Daniel Morgensztern

Importance: The National Comprehensive Cancer Network (NCCN) guidelines for non-small cell lung cancer suggest that RNA next-generation sequencing (NGS) may improve the detection of fusions and splicing variants compared with DNA-NGS alone. However, there is limited adoption of RNA-NGS in routine oncology clinical care today.

Objective: To analyze clinical evidence from a diverse cohort of patients with advanced lung adenocarcinoma and compare the detection of NCCN-recommended actionable structural variants (aSVs; fusions and splicing variants) via concurrent DNA and RNA-NGS vs DNA-NGS alone.

Design, setting, and participants: This multisite, retrospective cohort study examined patients sequenced between February 2021 and October 2023 within the deidentified, Tempus multimodal database, consisting of linked molecular and clinical data. Participants included patients with advanced lung adenocarcinoma and sufficient tissue sample quantities for both RNA-NGS and DNA-NGS testing.

Exposures: Received results from RNA-NGS and DNA-NGS solid-tissue profiling assays.

Main outcomes and measures: Detection rates of NCCN guideline-based structural variants (ALK, ROS1, RET and NTRK1/2/3 fusions, as well as MET exon 14 skipping splicing alterations) found uniquely by RNA-NGS.

Results: In the evaluable cohort of 5570 patients, median (IQR) age was 67.8 (61.3-75.4) years, and 2989 patients (53.7%) were female. The prevalence of actionable structural variants detected by either RNA-NGS or DNA-NGS was 8.8% (n = 491), with 86.7% (n = 426) of these detected by DNA-NGS. Concurrent RNA-NGS and DNA-NGS identified 15.3% more patients harboring aSVs compared with DNA-NGS alone (491 vs 426 patients, respectively), including 14.3% more patients harboring actionable fusions (376 vs 329 patients) and 18.6% more patients harboring MET exon 14 skipping alterations (115 vs 97 patients). There was no significant association between the assay used for aSV detection and aSV-targeted therapeutic adoption or clinical outcome. Emerging structural variants (eSVs) were found to have a combined prevalence to be 0.7%, with only 47.5% of eSVs detected by DNA-NGS.

Conclusions and relevance: In this cohort study, the detection of structural variants via concurrent RNA-NGS and DNA-NGS was higher across multiple NCCN-guideline recommended biomarkers compared with DNA-NGS alone, suggesting that RNA-NGS should be routinely implemented in the care of patients with advanced NSCLC.

重要性:美国国家综合癌症网络(NCCN)非小细胞肺癌指南建议,与单纯的 DNA-NGS 相比,RNA 下一代测序(NGS)可改善融合和剪接变异的检测。然而,RNA-NGS 目前在常规肿瘤临床治疗中的应用还很有限:目的:分析来自不同晚期肺腺癌患者队列的临床证据,并比较通过DNA和RNA-NGS同时检测NCCN推荐的可操作结构变异(aSVs;融合和剪接变异)与仅检测DNA-NGS的效果:这项多站点、回顾性队列研究对 2021 年 2 月至 2023 年 10 月期间在 Tempus 多模态数据库中进行测序的患者进行了检查,该数据库由关联的分子和临床数据组成。参与者包括晚期肺腺癌患者,并有足够的组织样本量进行 RNA-NGS 和 DNA-NGS 测试:主要结果和测量指标:RNA-NGS独特发现的基于NCCN指南的结构变异(ALK、ROS1、RET和NTRK1/2/3融合,以及MET第14外显子跳接改变)的检测率:在可评估的 5570 例患者中,中位(IQR)年龄为 67.8(61.3-75.4)岁,2989 例患者(53.7%)为女性。通过 RNA-NGS 或 DNA-NGS 检测到的可操作结构变异的发生率为 8.8%(n = 491),其中通过 DNA-NGS 检测到的变异占 86.7%(n = 426)。与单独检测 DNA-NGS 相比,同时检测 RNA-NGS 和 DNA-NGS 发现的 aSV 患者增加了 15.3%(分别为 491 例和 426 例),其中可检测融合的患者增加了 14.3%(376 例和 329 例),MET 第 14 外显子跳变的患者增加了 18.6%(115 例和 97 例)。用于检测 aSV 的检测方法与采用 aSV 靶向治疗或临床结果之间没有明显关联。研究发现,新出现的结构变异(eSVs)的综合发生率为 0.7%,而 DNA-NGS 检测到的 eSVs 仅占 47.5%:在这项队列研究中,与单独使用 DNA-NGS 相比,通过 RNA-NGS 和 DNA-NGS 同时检测多个 NCCN 指南推荐的生物标记物的结构变异率更高,这表明在晚期 NSCLC 患者的治疗中应常规使用 RNA-NGS。
{"title":"Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients With Advanced Non-Small Cell Lung Cancer.","authors":"Dwight Owen, Rotem Ben-Shachar, Josephine Feliciano, Lisa Gai, Kyle A Beauchamp, Zachary Rivers, Adam J Hockenberry, Genelle Harrison, John Guittar, Catarina Catela, Jerod Parsons, Ezra Cohen, Kate Sasser, Halla Nimeiri, Justin Guinney, Jyoti Patel, Daniel Morgensztern","doi":"10.1001/jamanetworkopen.2024.42970","DOIUrl":"10.1001/jamanetworkopen.2024.42970","url":null,"abstract":"<p><strong>Importance: </strong>The National Comprehensive Cancer Network (NCCN) guidelines for non-small cell lung cancer suggest that RNA next-generation sequencing (NGS) may improve the detection of fusions and splicing variants compared with DNA-NGS alone. However, there is limited adoption of RNA-NGS in routine oncology clinical care today.</p><p><strong>Objective: </strong>To analyze clinical evidence from a diverse cohort of patients with advanced lung adenocarcinoma and compare the detection of NCCN-recommended actionable structural variants (aSVs; fusions and splicing variants) via concurrent DNA and RNA-NGS vs DNA-NGS alone.</p><p><strong>Design, setting, and participants: </strong>This multisite, retrospective cohort study examined patients sequenced between February 2021 and October 2023 within the deidentified, Tempus multimodal database, consisting of linked molecular and clinical data. Participants included patients with advanced lung adenocarcinoma and sufficient tissue sample quantities for both RNA-NGS and DNA-NGS testing.</p><p><strong>Exposures: </strong>Received results from RNA-NGS and DNA-NGS solid-tissue profiling assays.</p><p><strong>Main outcomes and measures: </strong>Detection rates of NCCN guideline-based structural variants (ALK, ROS1, RET and NTRK1/2/3 fusions, as well as MET exon 14 skipping splicing alterations) found uniquely by RNA-NGS.</p><p><strong>Results: </strong>In the evaluable cohort of 5570 patients, median (IQR) age was 67.8 (61.3-75.4) years, and 2989 patients (53.7%) were female. The prevalence of actionable structural variants detected by either RNA-NGS or DNA-NGS was 8.8% (n = 491), with 86.7% (n = 426) of these detected by DNA-NGS. Concurrent RNA-NGS and DNA-NGS identified 15.3% more patients harboring aSVs compared with DNA-NGS alone (491 vs 426 patients, respectively), including 14.3% more patients harboring actionable fusions (376 vs 329 patients) and 18.6% more patients harboring MET exon 14 skipping alterations (115 vs 97 patients). There was no significant association between the assay used for aSV detection and aSV-targeted therapeutic adoption or clinical outcome. Emerging structural variants (eSVs) were found to have a combined prevalence to be 0.7%, with only 47.5% of eSVs detected by DNA-NGS.</p><p><strong>Conclusions and relevance: </strong>In this cohort study, the detection of structural variants via concurrent RNA-NGS and DNA-NGS was higher across multiple NCCN-guideline recommended biomarkers compared with DNA-NGS alone, suggesting that RNA-NGS should be routinely implemented in the care of patients with advanced NSCLC.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2442970"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis. 进餐时间与人体测量和代谢结果:系统回顾与元分析》。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.42163
Hiu Yee Liu, Ashley A Eso, Nathan Cook, Hayley M O'Neill, Loai Albarqouni

Importance: Meal timing strategies, such as time-restricted eating (TRE), reducing meal frequency, or altering calorie distribution across the day, have gained interest for their potential to enhance weight loss and metabolic health, particularly in managing chronic diseases, yet their long-term benefits are not known.

Objective: To evaluate the association between meal timing strategies (≥12 weeks) and anthropometric and metabolic indicators.

Data sources: Medline, Embase, CINAHL, and Cochrane CENTRAL were searched from inception to October 17, 2023.

Study selection: Randomized clinical trials, regardless of language and publication date, involving adults 18 years and older, evaluating within-day meal timing patterns for 12 or more weeks, and reporting anthropometric measures were included. Studies were excluded if participants had eating disorders, prior significant weight change, underwent bariatric surgery, were pregnant, or if controlled variables differed between groups.

Data extraction and synthesis: Study quality was determined via Risk of Bias 2.0 tool. Data were extracted independently by multiple reviewers. Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were used. Meta-analysis was performed using random-effects model on pooled continuous outcomes with 2 or more studies.

Main outcome and measures: Weight change in kilograms, reported as between-group mean difference with 95% CIs.

Results: Sixty-nine reports of 29 randomized clinical trials including 2485 individuals (1703 [69%] female; mean [SD] age, 44 [9.5] years; and mean [SD] body mass index, 33 [3.5]) were included. Study interventions included TRE (17 studies), meal frequency (8 studies), and calorie distribution (4 studies). There were some concerns of risk of bias for 7 studies and high concerns for 22 studies. Statistically significant weight change was observed in TRE when compared with control (-1.37 kg; 95% CI, -1.99 to -0.75 kg). Lower meal frequency and earlier caloric distribution were also both associated with greater change (-1.85 kg; 95% CI, -3.55 to -0.13 kg; and -1.75 kg; 95% CI, -2.37 to -1.13 kg, respectively).

Conclusions and relevance: The findings of this meta-analysis suggest that TRE, lower meal frequency, and earlier caloric distribution in the day may reduce weight compared with standard care and/or nutritional advice; however, the effect sizes found were small and of uncertain clinical importance. High heterogeneity and risk of bias among included studies led to concerns about the certainty of the underpinning evidence. Further research, including trials with larger sample sizes, standardized interventions with prescribed or matched energy intake, and longer follow-up, are needed.

重要性:进餐时间策略,如限时进餐(TRE)、减少进餐频率或改变一天中的卡路里分布,因其具有促进减肥和代谢健康的潜力而备受关注,尤其是在控制慢性疾病方面,但其长期益处尚不清楚:评估进餐时间策略(≥12 周)与人体测量和代谢指标之间的关联:数据来源:对 Medline、Embase、CINAHL 和 Cochrane CENTRAL 进行了检索,检索时间从开始到 2023 年 10 月 17 日:纳入的随机临床试验不限语言和出版日期,涉及 18 岁及以上的成年人,评估 12 周或更长时间的日内进餐时间模式,并报告人体测量指标。如果参与者患有饮食失调症、之前体重有显著变化、接受过减肥手术、怀孕或组间控制变量不同,则不纳入研究:研究质量通过偏倚风险 2.0 工具确定。数据由多名审稿人独立提取。采用《系统综述和荟萃分析首选报告项目》指南。采用随机效应模型对 2 项或 2 项以上研究的连续结果进行汇总,并进行 Meta 分析:主要结果和测量指标:以公斤为单位的体重变化,以组间平均差和 95% CIs 的形式报告:结果:共纳入 29 项随机临床试验的 69 份报告,包括 2485 人(1703 [69%] 为女性;平均 [SD] 年龄为 44 [9.5] 岁;平均 [SD] 体重指数为 33 [3.5])。研究干预措施包括 TRE(17 项研究)、进餐频率(8 项研究)和卡路里分配(4 项研究)。有 7 项研究存在一定的偏倚风险,22 项研究存在高度偏倚风险。与对照组相比,TRE 的体重变化具有统计学意义(-1.37 千克;95% CI,-1.99 至-0.75 千克)。较低的进餐频率和较早的热量分配也都与较大的变化有关(分别为-1.85千克;95% CI,-3.55至-0.13千克;以及-1.75千克;95% CI,-2.37至-1.13千克):这项荟萃分析的结果表明,与标准护理和/或营养建议相比,TRE、较低的进餐频率和一天中较早的热量分配可减轻体重;然而,所发现的效应大小较小,且临床重要性不确定。所纳入研究的高度异质性和偏倚风险导致人们对基础证据的确定性产生担忧。还需要进一步的研究,包括样本量更大的试验、规定或匹配能量摄入的标准化干预措施以及更长时间的随访。
{"title":"Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.","authors":"Hiu Yee Liu, Ashley A Eso, Nathan Cook, Hayley M O'Neill, Loai Albarqouni","doi":"10.1001/jamanetworkopen.2024.42163","DOIUrl":"10.1001/jamanetworkopen.2024.42163","url":null,"abstract":"<p><strong>Importance: </strong>Meal timing strategies, such as time-restricted eating (TRE), reducing meal frequency, or altering calorie distribution across the day, have gained interest for their potential to enhance weight loss and metabolic health, particularly in managing chronic diseases, yet their long-term benefits are not known.</p><p><strong>Objective: </strong>To evaluate the association between meal timing strategies (≥12 weeks) and anthropometric and metabolic indicators.</p><p><strong>Data sources: </strong>Medline, Embase, CINAHL, and Cochrane CENTRAL were searched from inception to October 17, 2023.</p><p><strong>Study selection: </strong>Randomized clinical trials, regardless of language and publication date, involving adults 18 years and older, evaluating within-day meal timing patterns for 12 or more weeks, and reporting anthropometric measures were included. Studies were excluded if participants had eating disorders, prior significant weight change, underwent bariatric surgery, were pregnant, or if controlled variables differed between groups.</p><p><strong>Data extraction and synthesis: </strong>Study quality was determined via Risk of Bias 2.0 tool. Data were extracted independently by multiple reviewers. Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were used. Meta-analysis was performed using random-effects model on pooled continuous outcomes with 2 or more studies.</p><p><strong>Main outcome and measures: </strong>Weight change in kilograms, reported as between-group mean difference with 95% CIs.</p><p><strong>Results: </strong>Sixty-nine reports of 29 randomized clinical trials including 2485 individuals (1703 [69%] female; mean [SD] age, 44 [9.5] years; and mean [SD] body mass index, 33 [3.5]) were included. Study interventions included TRE (17 studies), meal frequency (8 studies), and calorie distribution (4 studies). There were some concerns of risk of bias for 7 studies and high concerns for 22 studies. Statistically significant weight change was observed in TRE when compared with control (-1.37 kg; 95% CI, -1.99 to -0.75 kg). Lower meal frequency and earlier caloric distribution were also both associated with greater change (-1.85 kg; 95% CI, -3.55 to -0.13 kg; and -1.75 kg; 95% CI, -2.37 to -1.13 kg, respectively).</p><p><strong>Conclusions and relevance: </strong>The findings of this meta-analysis suggest that TRE, lower meal frequency, and earlier caloric distribution in the day may reduce weight compared with standard care and/or nutritional advice; however, the effect sizes found were small and of uncertain clinical importance. High heterogeneity and risk of bias among included studies led to concerns about the certainty of the underpinning evidence. Further research, including trials with larger sample sizes, standardized interventions with prescribed or matched energy intake, and longer follow-up, are needed.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2442163"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11530941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142557852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age and Late Recurrence in Young Patients With ER-Positive, ERBB2-Negative Breast Cancer. ER阳性、ERBB2阴性年轻乳腺癌患者的年龄与晚期复发
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.42663
Dong Seung Shin, Janghee Lee, Eunhye Kang, Dasom Noh, Jong-Ho Cheun, Jun-Hee Lee, Yeongyeong Son, Soong June Bae, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Byung-Joo Chae, Sunyoung Kwon, Han-Byoel Lee, Sung Gwe Ahn, Jai Min Ryu
<p><strong>Importance: </strong>Young patients with breast cancer with estrogen receptor (ER)-positive, ERBB2-negative tumors have a poor prognosis. Understanding factors influencing late recurrence is crucial for improving management and outcomes.</p><p><strong>Objective: </strong>To determine whether age is an independent factor associated with late distant recurrence (DR) in young patients with ER-positive, ERBB2-negative cancers without distant metastasis within 5 years from surgery.</p><p><strong>Design, setting, and participants: </strong>This multicenter retrospective cohort study analyzed clinical records of patients with breast cancer who underwent surgery from January 2000 to December 2011 with at least 5 years of follow-up. The study was conducted at Samsung Medical Center, Gangnam Severance Hospital, and Seoul National University Hospital, including patients aged 45 years or younger with ER-positive, ERBB2-negative tumors, no DR within 5 years after surgery, no neoadjuvant chemotherapy, and at least 2 years of endocrine therapy. The data analysis period was from January 4, 2023, to March 21, 2024.</p><p><strong>Exposure: </strong>Age, grouped as 21 to 35 years, 36 to 40 years, and 41 to 45 years.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was the incidence of late DR at 5 to 10 years after surgery. Survival outcomes, including late distant metastasis-free survival (DMFS), were evaluated in different age groups.</p><p><strong>Results: </strong>Among 2772 patients included, 370 (13.3%) were aged 21 to 35 years, 885 (31.9%) were aged 36 to 40 years, and 1517 (54.7%) were aged 41 to 45 years. The median (range) follow-up was 10.8 (5.0-21.4) years. The youngest group had a poorer histologic grade (eg, histologic grade 3: 107 patients aged 21-35 years [28.9%]; 149 patients aged 36-40 years [16.8%]; 273 patients aged 41-45 years [18.0%]) and more frequent chemotherapy (307 patients aged 21-35 years [83.0%]; 697 patients aged 36-40 years [78.8%]; 1111 patients aged 41-45 years [73.2%]). The youngest patients had significantly worse rates of locoregional recurrence-free survival (patients aged 21-35 years, 90.1% [95% CI, 86.8%-93.3%]; patients aged 36-40 years, 94.6% [95% CI, 93.0%-96.2%]; patients aged 41-45 years, 97.7% [95% CI, 96.9%-98.5%]), disease-free survival (patients aged 21-35 years, 79.3% [95% CI, 75.0%-83.9%]; patients aged 36-40 years, 88.7% [95% CI, 86.5%-91.0%]; patients aged 41-45 years, 94.4% [95% CI, 93.2%-95.7%]), and late DMFS (patients aged 21-35 years, 89.3% [95% CI, 86.0%-92.9%]; patients aged 36-40 years: 94.2% [95% CI, 92.5%-95.9%]; patients aged 41-45 years: 97.2% [95% CI, 96.3%-98.1%]) but not overall survival (patients aged 21-35 years, 96.9% [95% CI, 95.0%-98.9%]; patients aged 36-40 years, 98.2% [95% CI, 97.2%-99.2%]; patients aged 41-45 years, 98.9% [95% CI, 98.3%-99.5%]). Multivariable analysis showed lower hazard for late DR in the older groups compared with the youngest group (age
重要性:雌激素受体(ER)阳性、ERBB2阴性的年轻乳腺癌患者预后较差。了解影响晚期复发的因素对于改善管理和预后至关重要:目的:确定年龄是否是与ER阳性、ERBB2阴性、术后5年内无远处转移的年轻癌症患者晚期远处复发(DR)相关的独立因素:这项多中心回顾性队列研究分析了 2000 年 1 月至 2011 年 12 月期间接受手术治疗且随访至少 5 年的乳腺癌患者的临床记录。研究在三星医疗中心、江南Severance医院和首尔大学医院进行,包括年龄在45岁或以下、ER阳性、ERBB2阴性、术后5年内无DR、无新辅助化疗、至少接受过2年内分泌治疗的患者。数据分析期为 2023 年 1 月 4 日至 2024 年 3 月 21 日:年龄:21至35岁、36至40岁、41至45岁:主要结果是术后5至10年的晚期DR发生率。对不同年龄组的生存结果(包括晚期无远处转移生存率(DMFS))进行了评估:在纳入的2772名患者中,370人(13.3%)的年龄在21至35岁之间,885人(31.9%)的年龄在36至40岁之间,1517人(54.7%)的年龄在41至45岁之间。随访时间的中位数(范围)为 10.8(5.0-21.4)年。最年轻组患者的组织学分级较差(例如,组织学分级 3 级:21-35 岁患者 107 例 [28.9%];36-40 岁患者 149 例 [16.8%];41-45 岁患者 273 例 [18.0%]),化疗次数较多(21-35 岁患者 307 例 [83.0%];36-40 岁患者 697 例 [78.8%];41-45 岁患者 1111 例 [73.2%])。最年轻患者的无局部复发生存率(21-35 岁患者,90.1% [95% CI, 86.8%-93.3%]; 36-40 岁患者,94.6% [95% CI, 93.0%-96.2%]; 41-45 岁患者,97.7% [95% CI, 96.9%-98.5%])、无病生存期(21-35 岁患者,79.3% [95% CI,75.0%-83.9%];36-40 岁患者,88.7% [95% CI,86.5%-91.0%];41-45 岁患者,94.4% [95% CI,93.2%-95.7%])和晚期 DMFS(21-35 岁患者,89.3% [95% CI,86.0%-92.9%];36-40 岁患者,94.2% [95% CI,93.2%-95.7%]):94.2%[95%CI,92.5%-95.9%];41-45 岁患者:97.2%[95%CI,92.5%-95.9%]:总生存率(21-35 岁患者:96.9% [95% CI,95.0%-98.9%];36-40 岁患者:98.2% [95% CI,97.2%-99.2%];41-45 岁患者:98.9% [95% CI,98.3%-99.5%])。多变量分析显示,与最年轻的组别相比,年龄较大的组别发生晚期 DR 的风险较低(36-40 岁:风险比,0.53;95% CI,0.34-0.82;P = .001;41-45 岁:风险比,0.30;95% CI,0.20-0.47;P 结论及意义:在这项回顾性队列研究中,年龄是与ER阳性、ERBB2阴性的年轻乳腺癌患者晚期DR相关的一个独立因素。较小的年龄与较差的无局部复发生存率、无疾病生存率和晚期DMFS相关,突出了长期监测的重要性以及根据年龄采取个性化治疗方法的可能性,尤其是对于ER阳性、ERBB2阴性的年轻乳腺癌患者。
{"title":"Age and Late Recurrence in Young Patients With ER-Positive, ERBB2-Negative Breast Cancer.","authors":"Dong Seung Shin, Janghee Lee, Eunhye Kang, Dasom Noh, Jong-Ho Cheun, Jun-Hee Lee, Yeongyeong Son, Soong June Bae, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Byung-Joo Chae, Sunyoung Kwon, Han-Byoel Lee, Sung Gwe Ahn, Jai Min Ryu","doi":"10.1001/jamanetworkopen.2024.42663","DOIUrl":"10.1001/jamanetworkopen.2024.42663","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Young patients with breast cancer with estrogen receptor (ER)-positive, ERBB2-negative tumors have a poor prognosis. Understanding factors influencing late recurrence is crucial for improving management and outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To determine whether age is an independent factor associated with late distant recurrence (DR) in young patients with ER-positive, ERBB2-negative cancers without distant metastasis within 5 years from surgery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;This multicenter retrospective cohort study analyzed clinical records of patients with breast cancer who underwent surgery from January 2000 to December 2011 with at least 5 years of follow-up. The study was conducted at Samsung Medical Center, Gangnam Severance Hospital, and Seoul National University Hospital, including patients aged 45 years or younger with ER-positive, ERBB2-negative tumors, no DR within 5 years after surgery, no neoadjuvant chemotherapy, and at least 2 years of endocrine therapy. The data analysis period was from January 4, 2023, to March 21, 2024.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposure: &lt;/strong&gt;Age, grouped as 21 to 35 years, 36 to 40 years, and 41 to 45 years.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;The primary outcome was the incidence of late DR at 5 to 10 years after surgery. Survival outcomes, including late distant metastasis-free survival (DMFS), were evaluated in different age groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Among 2772 patients included, 370 (13.3%) were aged 21 to 35 years, 885 (31.9%) were aged 36 to 40 years, and 1517 (54.7%) were aged 41 to 45 years. The median (range) follow-up was 10.8 (5.0-21.4) years. The youngest group had a poorer histologic grade (eg, histologic grade 3: 107 patients aged 21-35 years [28.9%]; 149 patients aged 36-40 years [16.8%]; 273 patients aged 41-45 years [18.0%]) and more frequent chemotherapy (307 patients aged 21-35 years [83.0%]; 697 patients aged 36-40 years [78.8%]; 1111 patients aged 41-45 years [73.2%]). The youngest patients had significantly worse rates of locoregional recurrence-free survival (patients aged 21-35 years, 90.1% [95% CI, 86.8%-93.3%]; patients aged 36-40 years, 94.6% [95% CI, 93.0%-96.2%]; patients aged 41-45 years, 97.7% [95% CI, 96.9%-98.5%]), disease-free survival (patients aged 21-35 years, 79.3% [95% CI, 75.0%-83.9%]; patients aged 36-40 years, 88.7% [95% CI, 86.5%-91.0%]; patients aged 41-45 years, 94.4% [95% CI, 93.2%-95.7%]), and late DMFS (patients aged 21-35 years, 89.3% [95% CI, 86.0%-92.9%]; patients aged 36-40 years: 94.2% [95% CI, 92.5%-95.9%]; patients aged 41-45 years: 97.2% [95% CI, 96.3%-98.1%]) but not overall survival (patients aged 21-35 years, 96.9% [95% CI, 95.0%-98.9%]; patients aged 36-40 years, 98.2% [95% CI, 97.2%-99.2%]; patients aged 41-45 years, 98.9% [95% CI, 98.3%-99.5%]). Multivariable analysis showed lower hazard for late DR in the older groups compared with the youngest group (age ","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2442663"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis. 无病毒性肝炎或肝硬化成人肝细胞癌风险评分。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.43608
Ysabel C Ilagan-Ying, Kirsha S Gordon, Janet P Tate, Joseph K Lim, Jessie Torgersen, Vincent Lo Re, Amy C Justice, Tamar H Taddei
<p><strong>Importance: </strong>Hepatocellular carcinoma (HCC) is typically detected only at advanced stages when treatment options are limited. Most of the current HCC risk models focus on patients with viral hepatitis or diagnosed cirrhosis or require variables not routinely available in clinical care.</p><p><strong>Objective: </strong>To identify modifiable HCC risk factors in the general population and to develop a risk score to inform HCC screening and risk-factor modification interventions for high-risk individuals without viral hepatitis or decompensated cirrhosis.</p><p><strong>Design, setting, and participants: </strong>This cohort study analyzed demographic, clinical, laboratory, and diagnostic data from the US Department of Veterans Affairs (VA) electronic health records. Data were divided into development and validation samples. Veterans aged 30 to 95 years were included, and those with hepatitis B or C virus infection, hepatic decompensation, or prevalent HCC were excluded. Patients were followed up until the occurrence of HCC diagnosis, death, or December 31, 2021. A Cox proportional hazards regression model for 10-year risk of HCC was developed and used to create an HCC risk score, and performance in development and validation samples and in patient subgroups was evaluated. One outpatient visit date per person at least 18 months after VA entry, between October 1, 2007, and March 31, 2020, was randomly selected and used as the index date for the start of follow-up. Analyses were performed from March 2023 to May 2024.</p><p><strong>Exposures: </strong>Age, sex, race and ethnicity, body mass index, liver fibrosis (detected with Fibrosis-4 Index [FIB-4]), diabetes status, smoking status, and alcohol use.</p><p><strong>Main outcomes and measures: </strong>First HCC diagnosis during follow-up. This information was ascertained from VA national cancer registry topography and histology codes and from International Classification of Diseases, Ninth Revision and International Statistical Classification of Diseases, Tenth Revision, Clinical Modification diagnosis codes for the inpatient or outpatient visits.</p><p><strong>Results: </strong>This study of 6 509 288 veterans included 6 048 917 males (92.9%), with a median (IQR) age of 65 (54-74) years, who identified as being of Hispanic (5.3%), non-Hispanic Black (15.0%), non-Hispanic White (68.9%), or other (4.6%) race and ethnicity. Overall, 15 142 patients (0.2%) developed HCC, 69.5% of whom had FIB-4 of 3.25 or lower at baseline. While FIB-4 was the most important variable, age, sex, race and ethnicity, body mass index, diabetes, smoking, and alcohol use were also informative. Discrimination in the development sample was better than FIB-4 alone (C statistic, 0.83 [95% CI, 0.82-0.85] vs 0.79 [95% CI, 0.77-0.80]). The HCC risk score performed consistently well in the validation sample and in all subgroups. A FIB-4 threshold of 3.25 would screen 5.0% of the cohort at a cost of 28 false-positive
重要性:肝细胞癌(HCC)通常在晚期才被发现,此时治疗方案有限。目前大多数 HCC 风险模型都侧重于病毒性肝炎或确诊肝硬化患者,或需要临床护理中无法常规获得的变量:确定普通人群中可改变的 HCC 风险因素,并制定风险评分,为 HCC 筛查和针对无病毒性肝炎或肝硬化失代偿期的高危人群的风险因素改变干预措施提供依据:这项队列研究分析了美国退伍军人事务部(VA)电子健康记录中的人口统计学、临床、实验室和诊断数据。数据分为开发样本和验证样本。研究对象包括年龄在 30 至 95 岁之间的退伍军人,但不包括乙型或丙型肝炎病毒感染者、肝功能失代偿者或患有 HCC 的退伍军人。对患者进行随访,直至确诊 HCC、死亡或 2021 年 12 月 31 日。建立了一个 10 年 HCC 风险的 Cox 比例危险回归模型,用于创建 HCC 风险评分,并评估了开发样本、验证样本和患者亚组的性能。在 2007 年 10 月 1 日至 2020 年 3 月 31 日期间,随机抽取每人在进入退伍军人事务部至少 18 个月后的一个门诊就诊日期作为随访开始的指数日期。分析时间为 2023 年 3 月至 2024 年 5 月:年龄、性别、种族和民族、体重指数、肝纤维化(用纤维化-4指数[FIB-4]检测)、糖尿病状况、吸烟状况和饮酒情况:随访期间首次诊断出 HCC。这些信息来自退伍军人事务部国家癌症登记处的地形图和组织学代码,以及住院或门诊病人的《国际疾病分类》第九版和《国际疾病统计分类》第十版临床修订版诊断代码:这项对 6 509 288 名退伍军人进行的研究包括 6 048 917 名男性(92.9%),中位数(IQR)年龄为 65(54-74)岁,他们的种族和民族身份分别为西班牙裔(5.3%)、非西班牙裔黑人(15.0%)、非西班牙裔白人(68.9%)或其他(4.6%)。总体而言,15 142 名患者(0.2%)患上了 HCC,其中 69.5% 的患者基线时 FIB-4 为 3.25 或更低。虽然 FIB-4 是最重要的变量,但年龄、性别、种族和民族、体重指数、糖尿病、吸烟和酗酒也有一定的参考价值。开发样本的区分度优于单独的 FIB-4(C 统计量,0.83 [95% CI, 0.82-0.85] vs 0.79 [95% CI, 0.77-0.80])。在验证样本和所有亚组中,HCC 风险评分的表现始终良好。FIB-4阈值为3.25将筛查5.0%的人群,而每一个真阳性的代价是28个假阳性;模型风险评分为58将筛查4.7%的人群,而每一个真阳性的代价是23个假阳性:本研究结果表明,在识别基线时未患有病毒性肝炎或肝功能失代偿的 HCC 高危患者方面,使用常规临床数据的多变量风险评分优于单独使用 FIB-4。
{"title":"Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis.","authors":"Ysabel C Ilagan-Ying, Kirsha S Gordon, Janet P Tate, Joseph K Lim, Jessie Torgersen, Vincent Lo Re, Amy C Justice, Tamar H Taddei","doi":"10.1001/jamanetworkopen.2024.43608","DOIUrl":"10.1001/jamanetworkopen.2024.43608","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Hepatocellular carcinoma (HCC) is typically detected only at advanced stages when treatment options are limited. Most of the current HCC risk models focus on patients with viral hepatitis or diagnosed cirrhosis or require variables not routinely available in clinical care.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To identify modifiable HCC risk factors in the general population and to develop a risk score to inform HCC screening and risk-factor modification interventions for high-risk individuals without viral hepatitis or decompensated cirrhosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;This cohort study analyzed demographic, clinical, laboratory, and diagnostic data from the US Department of Veterans Affairs (VA) electronic health records. Data were divided into development and validation samples. Veterans aged 30 to 95 years were included, and those with hepatitis B or C virus infection, hepatic decompensation, or prevalent HCC were excluded. Patients were followed up until the occurrence of HCC diagnosis, death, or December 31, 2021. A Cox proportional hazards regression model for 10-year risk of HCC was developed and used to create an HCC risk score, and performance in development and validation samples and in patient subgroups was evaluated. One outpatient visit date per person at least 18 months after VA entry, between October 1, 2007, and March 31, 2020, was randomly selected and used as the index date for the start of follow-up. Analyses were performed from March 2023 to May 2024.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposures: &lt;/strong&gt;Age, sex, race and ethnicity, body mass index, liver fibrosis (detected with Fibrosis-4 Index [FIB-4]), diabetes status, smoking status, and alcohol use.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;First HCC diagnosis during follow-up. This information was ascertained from VA national cancer registry topography and histology codes and from International Classification of Diseases, Ninth Revision and International Statistical Classification of Diseases, Tenth Revision, Clinical Modification diagnosis codes for the inpatient or outpatient visits.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;This study of 6 509 288 veterans included 6 048 917 males (92.9%), with a median (IQR) age of 65 (54-74) years, who identified as being of Hispanic (5.3%), non-Hispanic Black (15.0%), non-Hispanic White (68.9%), or other (4.6%) race and ethnicity. Overall, 15 142 patients (0.2%) developed HCC, 69.5% of whom had FIB-4 of 3.25 or lower at baseline. While FIB-4 was the most important variable, age, sex, race and ethnicity, body mass index, diabetes, smoking, and alcohol use were also informative. Discrimination in the development sample was better than FIB-4 alone (C statistic, 0.83 [95% CI, 0.82-0.85] vs 0.79 [95% CI, 0.77-0.80]). The HCC risk score performed consistently well in the validation sample and in all subgroups. A FIB-4 threshold of 3.25 would screen 5.0% of the cohort at a cost of 28 false-positive","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2443608"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virtual Mental Health Care and Suicide-Related Events. 虚拟心理保健与自杀相关事件。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.43054
Kertu Tenso, Kiersten Strombotne, Melissa M Garrido, Jessica Lum, Steven Pizer

Importance: The rising suicide rates in the US emphasize the need for effective prevention. While telehealth has transformed access to mental health care, the impact of telehealth on suicide outcomes is unknown.

Objective: To evaluate the association of virtual mental health services with individual-level suicide-related events (SREs).

Design, setting, and participants: This retrospective cohort study using broadband access as an instrumental variable assessed a national sample of Veterans Health Administration patients who received mental health care between March 1, 2020, and December 31, 2021. Participants were recently separated (ie, discharged or released from active duty) veterans who completed their active duty service between March 1, 2019, and December 31, 2020, and who received at least 2 outpatient or inpatient diagnoses related to major depressive disorder, substance use disorder, or posttraumatic stress disorder within the year before their most recent separation date. Data were analyzed May 1 to October 31, 2023.

Exposure: Percentage of a patient's total mental health visits that were conducted virtually by psychiatrists, psychologists, or social workers within a calendar month.

Main outcomes and measures: Binary measure indicating whether the patient had experienced an SRE (defined as a nonfatal suicide attempt, intentional self-harm, or suicide death) in a specific month and year as evaluated an instrumental variable probit model.

Results: The sample included 66 387 data points from 16 236 unique recently separated veterans. Among these entries, 44 766 were for male veterans (67.4%), the mean (SD) age across the sample was 32.9 (8.9) years, and the sample was representative of the US veteran population. There were 929 SREs (1.4%). Virtual mental health visits comprised a mean (SD) of 44.6% (46.1%) of all mental health visits. In instrumental variable probit analyses accounting for factors simultaneously associated with use of virtual mental health care and SRE risk, a 1% increase in the probability of virtual mental health visits was associated with a 2.5% decrease in SREs.

Conclusions and relevance: Findings from this cohort study using a retrospective quasi-experimental design found that an increase in virtual mental health visits relative to total visits was associated with a statistically significant decrease in SREs, suggesting that providing virtual mental health services may reduce suicide-related outcomes.

重要性:美国自杀率的不断上升凸显了有效预防的必要性。虽然远程医疗改变了人们获得心理健康护理的途径,但远程医疗对自杀结果的影响尚不得而知:目的:评估虚拟心理健康服务与个人自杀相关事件(SREs)之间的关联:这项回顾性队列研究将宽带接入作为工具变量,评估了 2020 年 3 月 1 日至 2021 年 12 月 31 日期间接受过心理健康护理的退伍军人健康管理局患者的全国样本。参与者为最近离职(即从现役退伍或释放)的退伍军人,他们在 2019 年 3 月 1 日至 2020 年 12 月 31 日之间完成现役服役,并在最近离职日期前一年内接受过至少 2 次与重度抑郁障碍、药物使用障碍或创伤后应激障碍相关的门诊或住院诊断。数据分析时间为 2023 年 5 月 1 日至 10 月 31 日:主要结果和测量指标:通过工具变量 probit 模型评估患者在特定月份和年份是否经历过 SRE(定义为非致命性自杀未遂、蓄意自残或自杀死亡):样本包括 66 387 个数据点,分别来自 16 236 名刚退伍的退伍军人。在这些条目中,男性退伍军人占 44 766 人(67.4%),样本的平均(标清)年龄为 32.9(8.9)岁,样本在美国退伍军人群体中具有代表性。共有 929 例 SRE(1.4%)。虚拟心理健康就诊平均(标清)占所有心理健康就诊的 44.6%(46.1%)。在工具变量 probit 分析中,考虑到与使用虚拟心理保健和 SRE 风险同时相关的因素,虚拟心理保健就诊概率每增加 1%,SRE 就诊人数就会减少 2.5%:这项采用回顾性准实验设计的队列研究结果表明,虚拟心理健康就诊次数相对于总就诊次数的增加与自毁行为在统计学上的显著减少有关,这表明提供虚拟心理健康服务可能会减少与自杀相关的结果。
{"title":"Virtual Mental Health Care and Suicide-Related Events.","authors":"Kertu Tenso, Kiersten Strombotne, Melissa M Garrido, Jessica Lum, Steven Pizer","doi":"10.1001/jamanetworkopen.2024.43054","DOIUrl":"10.1001/jamanetworkopen.2024.43054","url":null,"abstract":"<p><strong>Importance: </strong>The rising suicide rates in the US emphasize the need for effective prevention. While telehealth has transformed access to mental health care, the impact of telehealth on suicide outcomes is unknown.</p><p><strong>Objective: </strong>To evaluate the association of virtual mental health services with individual-level suicide-related events (SREs).</p><p><strong>Design, setting, and participants: </strong>This retrospective cohort study using broadband access as an instrumental variable assessed a national sample of Veterans Health Administration patients who received mental health care between March 1, 2020, and December 31, 2021. Participants were recently separated (ie, discharged or released from active duty) veterans who completed their active duty service between March 1, 2019, and December 31, 2020, and who received at least 2 outpatient or inpatient diagnoses related to major depressive disorder, substance use disorder, or posttraumatic stress disorder within the year before their most recent separation date. Data were analyzed May 1 to October 31, 2023.</p><p><strong>Exposure: </strong>Percentage of a patient's total mental health visits that were conducted virtually by psychiatrists, psychologists, or social workers within a calendar month.</p><p><strong>Main outcomes and measures: </strong>Binary measure indicating whether the patient had experienced an SRE (defined as a nonfatal suicide attempt, intentional self-harm, or suicide death) in a specific month and year as evaluated an instrumental variable probit model.</p><p><strong>Results: </strong>The sample included 66 387 data points from 16 236 unique recently separated veterans. Among these entries, 44 766 were for male veterans (67.4%), the mean (SD) age across the sample was 32.9 (8.9) years, and the sample was representative of the US veteran population. There were 929 SREs (1.4%). Virtual mental health visits comprised a mean (SD) of 44.6% (46.1%) of all mental health visits. In instrumental variable probit analyses accounting for factors simultaneously associated with use of virtual mental health care and SRE risk, a 1% increase in the probability of virtual mental health visits was associated with a 2.5% decrease in SREs.</p><p><strong>Conclusions and relevance: </strong>Findings from this cohort study using a retrospective quasi-experimental design found that an increase in virtual mental health visits relative to total visits was associated with a statistically significant decrease in SREs, suggesting that providing virtual mental health services may reduce suicide-related outcomes.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2443054"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness of Temporary Financial Assistance for Veterans Experiencing Housing Instability. 为住房不稳定的退伍军人提供临时经济援助的成本效益。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.43396
Richard E Nelson, Alec Chapman, Thomas Byrne, Nathorn Chaiyakunapruk, Ying Suo, Atim Effiong, Warren Pettey, Lillian Gelberg, Stefan G Kertesz, Jack Tsai, Ann Elizabeth Montgomery

Importance: The US Department of Veterans Affairs (VA) partners with community organizations (grantees) across the US to provide temporary financial assistance (TFA) to vulnerable veterans through the Supportive Services for Veteran Families (SSVF) program. The goal of TFA for housing-related expenses is to prevent homelessness or to quickly house those who have become homeless.

Objective: To assess the cost-effectiveness of the SSVF program with TFA vs without TFA as an intervention for veterans who are experiencing housing insecurity.

Design, setting, and participants: This study used a Markov simulation model to compare cost and housing outcomes in a hypothetical cohort of veterans enrolled in the SSVF program. Enrollees who are homeless receive rapid rehousing services, while those who are at risk of becoming homeless receive homelessness prevention services.

Exposure: The SSVF program with TFA for veterans who are experiencing housing insecurity.

Main outcomes and measures: The effectiveness measure was the incremental cost-effectiveness ratio (ICER) with quality-adjusted life-years (QALYs). The model was parameterized using a combination of inputs taken from published literature and internal VA data. The model had a 2-year time horizon and a 1-day cycle length. In addition, probabilistic sensitivity analyses were conducted using 10 000 Monte Carlo simulations.

Results: The base case analyses found that the SSVF program with TFA was more costly ($35 814 vs $32 562) and yielded more QALYs (1.541 vs 1.398) than the SSVF program without TFA. The resulting ICER was $22 676 per QALY, indicating that TFA is the preferred strategy at a willingness-to-pay threshold of $150 000 per QALY. This ICER was $19 114 per QALY for veterans in the rapid rehousing component of the SSVF program and $29 751 per QALY for those in the homelessness prevention component of the SSVF program. At a willingness-to-pay threshold of $150 000 per QALY, probabilistic sensitivity analyses showed that TFA was cost-effective in 8972 of the 10 000 Monte Carlo simulations (89.7%) for rapid rehousing and in 8796 of the 10 000 Monte Carlo simulations (88.0%) for homelessness prevention only.

Conclusions and relevance: This economic evaluation suggests that TFA is a cost-effective approach (ie, yields improved health benefits at a reasonable cost) for addressing housing insecurity for veterans enrolling in the SSVF program. Future research could examine the cost effectiveness of large, nationwide housing interventions such as this one among subpopulations of veterans such as those with certain comorbidities including severe mental illness or substance use disorders, those with chronic diseases, or those experiencing long-term housing instability vs acute loss of housing.

重要性:美国退伍军人事务部 (VA) 与美国各地的社区组织(受赠方)合作,通过退伍军人家庭支助服务 (SSVF) 计划为弱势退伍军人提供临时经济援助 (TFA)。临时经济援助用于支付与住房有关的费用,目的是防止无家可归或迅速安置那些无家可归的人:目的:评估退伍军人家庭支助服务(SSVF)计划中使用全额补贴与不使用全额补贴作为对住房无保障的退伍军人进行干预的成本效益:本研究采用马尔可夫模拟模型,对参加 SSVF 计划的退伍军人假定群体的成本和住房结果进行比较。无家可归的参加者接受快速安置服务,而面临无家可归风险的参加者则接受无家可归预防服务:有效性的衡量标准是增量成本效益比(ICER)和质量调整生命年(QALYs)。该模型的参数设置结合了已发表文献和退伍军人事务部的内部数据。模型的时间跨度为 2 年,周期长度为 1 天。此外,还使用 10 000 次蒙特卡罗模拟进行了概率敏感性分析:基础病例分析发现,与不使用 TFA 的 SSVF 方案相比,使用 TFA 的 SSVF 方案成本更高(35 814 美元 vs 32 562 美元),而 QALYs(1.541 vs 1.398)更多。由此得出的 ICER 为每 QALY 22 676 美元,表明在每 QALY 150 000 美元的支付意愿阈值下,TFA 是首选策略。对于参加 SSVF 项目中快速安置部分的退伍军人,该 ICER 为每 QALY 19 114 美元;对于参加 SSVF 项目中无家可归预防部分的退伍军人,该 ICER 为每 QALY 29 751 美元。在每 QALY 150 000 美元的支付意愿阈值下,概率敏感性分析表明,在 10 000 次 Monte Carlo 模拟中,有 8 972 次(89.7%)的快速安置项目中,TFA 具有成本效益;在 10 000 次 Monte Carlo 模拟中,有 8796 次(88.0%)的无家可归预防项目中,TFA 仅具有成本效益:这项经济评估表明,TFA 是一种具有成本效益的方法(即以合理的成本获得更好的健康效益),可用于解决加入 SSVF 计划的退伍军人的住房不安全问题。未来的研究可以在退伍军人的子人群中,如患有某些合并症(包括严重精神疾病或药物使用障碍)、慢性病或经历长期住房不稳定与急性失去住房的退伍军人中,研究像该项目这样的全国性大型住房干预措施的成本效益。
{"title":"Cost-Effectiveness of Temporary Financial Assistance for Veterans Experiencing Housing Instability.","authors":"Richard E Nelson, Alec Chapman, Thomas Byrne, Nathorn Chaiyakunapruk, Ying Suo, Atim Effiong, Warren Pettey, Lillian Gelberg, Stefan G Kertesz, Jack Tsai, Ann Elizabeth Montgomery","doi":"10.1001/jamanetworkopen.2024.43396","DOIUrl":"10.1001/jamanetworkopen.2024.43396","url":null,"abstract":"<p><strong>Importance: </strong>The US Department of Veterans Affairs (VA) partners with community organizations (grantees) across the US to provide temporary financial assistance (TFA) to vulnerable veterans through the Supportive Services for Veteran Families (SSVF) program. The goal of TFA for housing-related expenses is to prevent homelessness or to quickly house those who have become homeless.</p><p><strong>Objective: </strong>To assess the cost-effectiveness of the SSVF program with TFA vs without TFA as an intervention for veterans who are experiencing housing insecurity.</p><p><strong>Design, setting, and participants: </strong>This study used a Markov simulation model to compare cost and housing outcomes in a hypothetical cohort of veterans enrolled in the SSVF program. Enrollees who are homeless receive rapid rehousing services, while those who are at risk of becoming homeless receive homelessness prevention services.</p><p><strong>Exposure: </strong>The SSVF program with TFA for veterans who are experiencing housing insecurity.</p><p><strong>Main outcomes and measures: </strong>The effectiveness measure was the incremental cost-effectiveness ratio (ICER) with quality-adjusted life-years (QALYs). The model was parameterized using a combination of inputs taken from published literature and internal VA data. The model had a 2-year time horizon and a 1-day cycle length. In addition, probabilistic sensitivity analyses were conducted using 10 000 Monte Carlo simulations.</p><p><strong>Results: </strong>The base case analyses found that the SSVF program with TFA was more costly ($35 814 vs $32 562) and yielded more QALYs (1.541 vs 1.398) than the SSVF program without TFA. The resulting ICER was $22 676 per QALY, indicating that TFA is the preferred strategy at a willingness-to-pay threshold of $150 000 per QALY. This ICER was $19 114 per QALY for veterans in the rapid rehousing component of the SSVF program and $29 751 per QALY for those in the homelessness prevention component of the SSVF program. At a willingness-to-pay threshold of $150 000 per QALY, probabilistic sensitivity analyses showed that TFA was cost-effective in 8972 of the 10 000 Monte Carlo simulations (89.7%) for rapid rehousing and in 8796 of the 10 000 Monte Carlo simulations (88.0%) for homelessness prevention only.</p><p><strong>Conclusions and relevance: </strong>This economic evaluation suggests that TFA is a cost-effective approach (ie, yields improved health benefits at a reasonable cost) for addressing housing insecurity for veterans enrolling in the SSVF program. Future research could examine the cost effectiveness of large, nationwide housing interventions such as this one among subpopulations of veterans such as those with certain comorbidities including severe mental illness or substance use disorders, those with chronic diseases, or those experiencing long-term housing instability vs acute loss of housing.</p>","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2443396"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539017/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Goals of Surgical Interventions in Youths Receiving Palliative Care. 接受姑息治疗的青少年的手术干预目标。
IF 10.5 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-04 DOI: 10.1001/jamanetworkopen.2024.44072
Danielle I Ellis, Li Chen, Samara Gordon Wexler, Madeline Avery, Tommy D Kim, Amy J Kaplan, Emanuele Mazzola, Cassandra Kelleher, Joanne Wolfe
<p><strong>Importance: </strong>Most youths receiving palliative care undergo many surgical interventions over their lifetimes. The intended purposes of interventions in the context of goals of care are not commonly articulated.</p><p><strong>Objective: </strong>To describe the goals and purposes of surgical intervention in youths receiving palliative care and propose a framework discussing intervention using goal-oriented language.</p><p><strong>Design, setting, and participants: </strong>This retrospective cohort analysis was conducted among a subset of patients enrolled between April 2017 and March 2021 in a prospective multicenter cohort study of youths receiving palliative care (the Pediatric Palliative Care Research Network's Shared Data and Research [SHARE] Study). Patients younger than 30 years receiving palliative care services were eligible for inclusion in SHARE, and all enrolled at Boston Children's Hospital/Dana Farber Cancer Institute, a SHARE site, were included in this study. Goals and purposes of all surgical interventions from the time of diagnosis through the present were abstracted from patient records. A goal and purpose framework was generated using a hybrid deductive-inductive approach based on established goals-of-care frameworks and the clinical context of surgical interventions. Data were analyzed in September 2023.</p><p><strong>Main outcomes and measures: </strong>Primary outcomes included goals and purposes of surgical interventions performed in the study population.</p><p><strong>Results: </strong>Among 197 youths receiving palliative care (mean [SD] age at palliative care start, 8.01 [7.53] years; 108 male [54.8%]; 6 Asian [3.0%], 12 Black [6.1%], 129 White [65.5%], and 16 with >1 race [8.1%]; 27 Hispanic [13.7%] and 142 not Hispanic [72.1%]), almost all individuals (189 youths [95.9%]) underwent at least 1 surgical intervention (mean [SD] 17.5 [16.3] interventions; median [IQR] 13 [5-22] interventions). Of 3331 surgical interventions, there were 878 interventions (26.5%) conducted with the goal of life extension, 1229 interventions (37.1%) conducted for life enhancement, and 79 interventions (2.4%) conducted for both goals; the remaining 1130 interventions (34.1%) held neither goal. Most interventions were performed with the purpose of diagnosis (1092 interventions [32.9%]) or cure and repair (1055 interventions [31.8%]), with fewer performed for the purpose of placing or maintaining assistive technology (696 interventions [21.0%]) or for supportive (434 interventions [13.1%]) or temporizing (39 interventions [1.2%]) purposes. Patients with cardiovascular disease and cancers constituted approximately half (592 patients [56.1%]) of those undergoing curative or repair interventions, whereas youths with neurologic or genetic conditions constituted approximately half (244 patients [56.2%]) of those undergoing supportive interventions.</p><p><strong>Conclusions and relevance: </strong>In this cohort study, nearly all yo
重要性:大多数接受姑息关怀的青少年在其一生中会经历许多外科干预。在姑息关怀目标的背景下,干预的预期目的并不常见:描述接受姑息关怀的青少年接受外科干预的目标和目的,并提出使用目标导向语言讨论干预的框架:这项回顾性队列分析是在2017年4月至2021年3月期间参加一项针对接受姑息治疗的青少年的前瞻性多中心队列研究(儿科姑息治疗研究网络的共享数据和研究[SHARE]研究)的患者子集中进行的。接受姑息治疗服务的患者年龄小于30岁,符合SHARE的纳入条件,所有在波士顿儿童医院/达纳法伯癌症研究所(SHARE的研究机构)登记的患者均纳入本研究。研究人员从患者病历中摘录了从确诊到现在所有手术干预的目标和目的。根据已建立的护理目标框架和手术干预的临床背景,采用演绎-归纳混合方法生成了目标和目的框架。数据分析于 2023 年 9 月完成:主要结果包括研究人群进行外科干预的目标和目的:在接受姑息关怀的 197 名青少年中(姑息关怀开始时的平均[标度]年龄为 8.01 [7.53] 岁;108 名男性[54.8%];6 名亚裔[3.0%]、12 名黑人[6.1%]、129 名白人[65.5%]、16 名种族>1[8.1%];27 名西班牙裔[13.7%]和 142 名非西班牙裔[72.1%]),几乎所有人(189 名青少年[95.9%])都至少接受过一次手术干预(平均[标度] 17.5 [16.3] 次干预;中位数[IQR] 13 [5-22] 次干预)。在 3331 例手术干预中,有 878 例(26.5%)以延长生命为目的,1229 例(37.1%)以延长生命为目的,79 例(2.4%)同时以延长生命和延长生命为目的;其余 1130 例(34.1%)既不以延长生命为目的,也不以延长生命为目的。大多数干预的目的是诊断(1092 次干预 [32.9%])或治疗和修复(1055 次干预 [31.8%]),较少干预是为了安置或维护辅助技术(696 次干预 [21.0%])或支持性(434 次干预 [13.1%])或临时性(39 次干预 [1.2%])目的。在接受治疗性或修复性干预的患者中,心血管疾病和癌症患者约占一半(592 名患者 [56.1%]),而在接受支持性干预的患者中,患有神经或遗传疾病的青少年约占一半(244 名患者 [56.2%]):在这项队列研究中,几乎所有青少年都接受了手术干预,而干预的目的则因重病类型而异。这些研究结果表明,以手术干预的目标和目的的建议框架为中心进行对话,可促进为患有严重疾病的青少年提供目标一致的高质量护理。
{"title":"Goals of Surgical Interventions in Youths Receiving Palliative Care.","authors":"Danielle I Ellis, Li Chen, Samara Gordon Wexler, Madeline Avery, Tommy D Kim, Amy J Kaplan, Emanuele Mazzola, Cassandra Kelleher, Joanne Wolfe","doi":"10.1001/jamanetworkopen.2024.44072","DOIUrl":"10.1001/jamanetworkopen.2024.44072","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Most youths receiving palliative care undergo many surgical interventions over their lifetimes. The intended purposes of interventions in the context of goals of care are not commonly articulated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To describe the goals and purposes of surgical intervention in youths receiving palliative care and propose a framework discussing intervention using goal-oriented language.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;This retrospective cohort analysis was conducted among a subset of patients enrolled between April 2017 and March 2021 in a prospective multicenter cohort study of youths receiving palliative care (the Pediatric Palliative Care Research Network's Shared Data and Research [SHARE] Study). Patients younger than 30 years receiving palliative care services were eligible for inclusion in SHARE, and all enrolled at Boston Children's Hospital/Dana Farber Cancer Institute, a SHARE site, were included in this study. Goals and purposes of all surgical interventions from the time of diagnosis through the present were abstracted from patient records. A goal and purpose framework was generated using a hybrid deductive-inductive approach based on established goals-of-care frameworks and the clinical context of surgical interventions. Data were analyzed in September 2023.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;Primary outcomes included goals and purposes of surgical interventions performed in the study population.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Among 197 youths receiving palliative care (mean [SD] age at palliative care start, 8.01 [7.53] years; 108 male [54.8%]; 6 Asian [3.0%], 12 Black [6.1%], 129 White [65.5%], and 16 with &gt;1 race [8.1%]; 27 Hispanic [13.7%] and 142 not Hispanic [72.1%]), almost all individuals (189 youths [95.9%]) underwent at least 1 surgical intervention (mean [SD] 17.5 [16.3] interventions; median [IQR] 13 [5-22] interventions). Of 3331 surgical interventions, there were 878 interventions (26.5%) conducted with the goal of life extension, 1229 interventions (37.1%) conducted for life enhancement, and 79 interventions (2.4%) conducted for both goals; the remaining 1130 interventions (34.1%) held neither goal. Most interventions were performed with the purpose of diagnosis (1092 interventions [32.9%]) or cure and repair (1055 interventions [31.8%]), with fewer performed for the purpose of placing or maintaining assistive technology (696 interventions [21.0%]) or for supportive (434 interventions [13.1%]) or temporizing (39 interventions [1.2%]) purposes. Patients with cardiovascular disease and cancers constituted approximately half (592 patients [56.1%]) of those undergoing curative or repair interventions, whereas youths with neurologic or genetic conditions constituted approximately half (244 patients [56.2%]) of those undergoing supportive interventions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;In this cohort study, nearly all yo","PeriodicalId":14694,"journal":{"name":"JAMA Network Open","volume":"7 11","pages":"e2444072"},"PeriodicalIF":10.5,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA Network Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1